arrow
R

Richard Good

university of glasgow
H指数:18
被引数:2,532

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stratified medicine with eplerenone for myocardial infarction or injury and no obstructive coronary arteries: A registry-based basket trial

依普利酮在心肌梗死或损伤且无阻塞性冠状动脉病变患者中的分层医学研究:一项基于注册登记的篮式试验

2026-07-010
PRE
Endotype-informed therapy and effects on illness perception and psychological health in patients with chest pain and no obstructive coronary artery disease

基于内表型的治疗及其对无阻塞性冠状动脉疾病伴胸痛患者疾病感知与心理健康的影响

2026-06-040
OAAI
Pre-perfusion coronary wedge pressure and microvascular obstruction in anterior ST elevation myocardial infarction (STEMI): An analysis from the EUROICE study

术前灌注冠状动脉楔压和前壁ST段抬高型心肌梗死(STEMI)中的微血管阻塞:来自EUROICE研究的分析

2026-05-220
PRE
Fractional flow reserve vs angiography in non-ST- elevation myocardial infarction: long-term results of the FAMOUS-NSTEMI trial

分叉病变的血流储备分数与血管造影术比较:FAMOUS-NSTEMI试验的长期结果

2025-12-010
OAAI
Endotyping-informed therapy for patients with chest pain and no obstructive coronary artery disease: a randomized trial
2025-11-100
OAAI
Infarct-Related Myocardial Resistance Before Reperfusion in Patients With Acute Myocardial Infarction to Predict Microvascular Injury and Clinical Outcomes

急性心肌梗死患者再灌注前梗死相关心肌阻力对微血管损伤和临床结局的预测作用

2025-11-011
PRE
Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI)

Empliflozin预防心肌梗死后左心室容积和收缩功能恶化 (EMPRESS MI)

2024-12-150
PRE
Coronary microvascular function and atherosclerotic plaque burden in ischaemia and no obstructive coronary arteries: a secondary analysis of the CorMicA trial
HEART
IF4.4
2024-11-271
OAAI
A randomised trial of selective intracoronary hypothermia during primary PCI
2024-06-012
PRE
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design

Empagliflozin预防心肌梗死后进行性不良重塑 (empress-mi): 原理和设计

2024-05-075
OA
Fractional Flow Reserve-Guided Stent Optimisation in Focal and Diffuse Coronary Artery Disease
2023-08-072
OAAI
Angina After Percutaneous Coronary Intervention: Patient and Procedural Predictors
2023-04-0115
OAAI
Rationale and design of the effect of mineralocorticoid receptor antagonist therapy in patients with acute myocardial infarction or injury and non-obstructive coronary arteries: a registry-based, stratified-medicine, randomised, controlled trial
HEART
IF4.4
2023-01-280
OA